Alphabet's life sciences business Verily is restructuring and raising money as a new corporate entity. Verily announced that with its $300 million investment round, it will change from an LLC to a corporation and rename itself Verily Health Inc. As a result, Alphabet now has a minority stake rather than a controlling one in the …
Alphabet no longer has a controlling stake in its life sciences business Verily
Alphabet’s life sciences business Verily is restructuring and raising money as a new corporate entity. Verily announced that with its $300 million investment round, it will change from an LLC to a corporation and rename itself Verily Health Inc. As a result, Alphabet now has a minority stake rather than a controlling one in the business.
Similar to every other tech business, this chapter for Verily will be focused on AI. “From research to care, our customers need solutions that bring the best of clinical and scientific rigor together with AI to deliver the next generation of healthcare – one that is as precise as it is personal,” Chairman and CEO Stephen Gillett said.
Google Life Sciences was renamed Verily in 2015, around the same time as Google also rebranded to Alphabet. It has worked on a wide range of projects over the years, such as using eye scans to predict heart disease and an opioid addiction center. In 2025, it closed its medical device division, a move that may have signaled its shift toward AI.
This article originally appeared on Engadget at https://www.engadget.com/big-tech/alphabet-no-longer-has-a-controlling-stake-in-its-life-sciences-business-verily-221718631.html?src=rss
Ashley Reymond
Ashley Reymond brings a unique blend of cultural fluency and economic insight to her writing. With a background in journalism and behavioral economics, she seamlessly connects lifestyle, fashion, and finance with global market trends. Her work often explores the intersection of social movements and economic shifts. Off-hours, she’s a lover of contemporary art and minimalist design.
